Nanoparticle therapeutic restores tumor suppressor, sensitizes cancer cells to treatment

Leveraging advancements in nanotechnology, investigators from the Brigham have found that restoring p53 not only delays the growth of p53-deficient liver and lung cancer cells but may also make tumors more vulnerable to cancer drugs known as mTOR inhibitors.

Read the full article here

Related Articles